CAVIM
CAVIM CAVIM is an advanced combination antibiotic formulation containing Ceftazidime, a third-generation cephalosporin, and Avibactam, a non-beta-lactam beta-lactamase inhibitor. Ceftazidime works by inhibiting bacterial cell wall synthesis, while Avibactam protects Ceftazidime from breakdown by neutralizing extended-spectrum beta-lactamases (ESBLs) and Klebsiella pneumoniae carbapenemases (KPCs). This powerful dual action restores and enhances antibacterial efficacy against multidrug-resistant Gram-negative pathogens, making it vital for treating complicated intra-abdominal infections, severe urinary tract infections (including pyelonephritis), and hospital-acquired pneumonia.
| Brand | CAVIM |
| Storage Temperature | Store below 25°C in a dry place (Protect from light) |
| Prescription Needed | Yes |
| Composition | Ceftazidime Sodium equivalent to Anhydrous Ceftazidime + Avibactam Sodium equivalent to Avibactam |
| Strength | 2.5 g per vial |
| Form | Sterile Powder for Concentrate for Solution for Infusion |
| Pack Size | 1 Vial |
| Packaging | Single-use glass vial |
| Country of Origin | Made In India |
| Manufacturer | Gufic Biosciences Limited (Gufic CitiCare) |
CAVIM
CAVIM CAVIM is an advanced combination antibiotic formulation containing Ceftazidime, a third-generation cephalosporin, and Avibactam, a non-beta-lactam beta-lactamase inhibitor. Ceftazidime works by inhibiting bacterial cell wall synthesis, while Avibactam protects Ceftazidime from breakdown by neutralizing extended-spectrum beta-lactamases (ESBLs) and Klebsiella pneumoniae carbapenemases (KPCs). This powerful dual action restores and enhances antibacterial efficacy against multidrug-resistant Gram-negative pathogens, making it vital for treating complicated intra-abdominal infections, severe urinary tract infections (including pyelonephritis), and hospital-acquired pneumonia.
